絞り込み

16643

広告

診療報酬「本体」0.55%引き上げ 前回と同水準 政府方針 (毎日新聞)

麻生太郎副総理兼財務相=川田雅浩撮影 [PR] 政府は13日、2020年度の診療報酬の改定で、医師の技術料にあたる「本体部分」を0・55%引き上げる方針を固めた...

  1. ベースラインctDNA解析での変異の有無...
  2. 脳転移患者も含む多数の治療歴を持つHER...
  3. 手術可能なルミナールB乳癌の術前療法でr...
  4. TNBCの術前化学療法へのペムブロリズマ...

ニュース一覧

Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis.

著者 Dentali F , Di Minno MN , Turato S , Crestani S , Ambrosino P , Bonfanti C , Di Minno G , Ageno W , Franchini M
Thromb Res.2014 May 15 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (87view , 0users)

Full Text Sources

Medical

The presence of residual vein obstruction (RVO) has been consistently associated with an increased risk of post-thrombotic syndrome in patients with a previous deep vein thrombosis (DVT) and there is some evidence suggesting an increased risk of DVT recurrence. Only few studies have assessed potential risk factors for RVO. In this study, we evaluated whether ABO blood group with or without associated thrombophilic abnormalities is associated with RVO after a standard course of anticoagulation for a first DVT. Patients with a first DVT who underwent screening for thrombophilic abnormalities were eligible for this study. Information was collected on ABO blood group and on risk factors for DVT. Each patient underwent compression ultrasonography of the lower limbs for the detection of RVO at least 6months after a standard course of anticoagulant treatment. A total of 268 patients (mean age 50.3years, 120 women) were included. After 8.3±2.9months of anticoagulant treatment, 126 (47.0%) patients had RVO. At multivariate analysis, active malignancy (Odds Ratios [OR] 5.54, 95% confidence interval [CI] 2.17, 14.13), non-O blood group (OR 3.71, 95% CI 1.61, 8.56), and femoral involvement (OR 3.35 95% CI 1.94, 5.78) were significantly associated with RVO whereas an unprovoked index event was only marginally significant (OR 1.81 95% CI 0.98, 3.36 p 0.06) and severe thrombophilia was not associated with RVO (OR 1.32 95% CI 0.56, 3.11). After a standard course of anticoagulation for a first DVT, patients with non-O blood group are at increased risk of RVO.
PMID: 24882273 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード